DEBIASED INVERSE PROPENSITY SCORE WEIGHTING FOR ESTIMATION OF AVERAGE TREATMENT EFFECTS WITH HIGH-DIMENSIONAL CONFOUNDERS

被引:0
|
作者
Wang, Yuhao [1 ]
Shah, Rajen d. [2 ]
机构
[1] Tsinghua Univ, Inst Interdisciplinary Informat Sci, Beijing, Peoples R China
[2] Univ Cambridge, Stat Lab, Cambridge, England
来源
ANNALS OF STATISTICS | 2024年 / 52卷 / 05期
基金
中国国家自然科学基金; 英国工程与自然科学研究理事会;
关键词
Causal inference; high dimensional statistics; inverse propensity score weighting; de- biased inference; model robustness; GENERALIZED LINEAR-MODELS; CONFIDENCE-INTERVALS; INFERENCE; PARAMETERS; SELECTION;
D O I
10.1214/24-AOS2409
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
We consider estimation of average treatment effects given observational data with high-dimensional pretreatment variables. Existing methods for this problem typically assume some form of sparsity for the regression functions. In this work, we introduce a debiased inverse propensity score weighting (DIPW) scheme for average treatment effect estimation that delivers root nconsistent estimates when the propensity score follows a sparse logistic regression model; the outcome regression functions are permitted to be arbitrarily complex. We further demonstrate how confidence intervals centred on our estimates may be constructed. Our theoretical results quantify the price to pay for permitting the regression functions to be unestimable, which shows up as an inflation of the variance of the estimator compared to the semiparametric efficient variance by a constant factor, under mild conditions. We also show that when outcome regressions can be estimated consistently, our estimator achieves semiparametric efficiency. As our results accommodate arbitrary outcome regression functions, averages of transformed responses under each treatment may also be estimated at the root n rate. Thus, for example, the variances of the potential outcomes may be estimated. We discuss extensions to estimating linear projections of the heterogeneous treatment effect function and explain how propensity score models with more general link functions may be handled within our framework. An R package dipw implementing our methodology is available on CRAN.
引用
收藏
页码:1978 / 2003
页数:26
相关论文
共 50 条
  • [31] Estimation of average treatment effects based on propensity scores
    Becker, Sascha O.
    Ichino, Andrea
    STATA JOURNAL, 2002, 2 (04): : 358 - 377
  • [32] Confidence intervals for high-dimensional inverse covariance estimation
    Jankova, Jana
    van de Geer, Sara
    ELECTRONIC JOURNAL OF STATISTICS, 2015, 9 (01): : 1205 - 1229
  • [33] Propensity score prediction for electronic healthcare databases using super learner and high-dimensional propensity score methods
    Ju, Cheng
    Combs, Mary
    Lendle, Samuel D.
    Franklin, Jessica M.
    Wyss, Richard
    Schneeweiss, Sebastian
    van der Laan, Mark J.
    JOURNAL OF APPLIED STATISTICS, 2019, 46 (12) : 2216 - 2236
  • [34] Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting
    Tazare, John
    Wyss, Richard
    Franklin, Jessica M.
    Smeeth, Liam
    Evans, Stephen J. W.
    Wang, Shirley V.
    Schneeweiss, Sebastian
    Douglas, Ian J.
    Williamson, Elizabeth
    Gagne, Joshua J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 387 - 387
  • [35] Challenges With Propensity Score Strategies in a High-Dimensional Setting and a Potential Alternative
    Hill, Jennifer
    Weiss, Christopher
    Zhai, Fuhua
    MULTIVARIATE BEHAVIORAL RESEARCH, 2011, 46 (03) : 477 - 513
  • [36] Evaluation of propensity score methods for causal inference with high-dimensional covariates
    Gao, Qian
    Zhang, Yu
    Sun, Hongwei
    Wang, Tong
    BRIEFINGS IN BIOINFORMATICS, 2022, 23 (04)
  • [37] Propensity Score Prediction for Electronic Healthcare Databases Using Super Learner and High-Dimensional Propensity Score Methods
    Ju, Cheng
    Combs, Mary
    Lendle, Samuel D.
    Franklin, Jessica M.
    Wyss, Richard
    Schneeweiss, Sebastian
    van der Laan, Mark
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 421 - 422
  • [38] Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting
    Tazare, John
    Wyss, Richard
    Franklin, Jessica M.
    Smeeth, Liam
    Evans, Stephen J. W.
    Wang, Shirley, V
    Schneeweiss, Sebastian
    Douglas, Ian J.
    Gagne, Joshua J.
    Williamson, Elizabeth J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (04) : 411 - 423
  • [39] Estimation of high-dimensional propensity scores with multiple exposure levels
    Eberg, Maria
    Platt, Robert W.
    Reynier, Pauline
    Filion, Kristian B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 53 - 60
  • [40] Letter in response to Schneeweiss and Rassen on the high-dimensional propensity score approach
    Toh, Sengwee
    Garcia Rodriguez, Luis A.
    Hernan, Miguel A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (10) : 1112 - 1112